BioCentury
ARTICLE | Company News

Endece, Myelin Repair Foundation deal

February 13, 2012 8:00 AM UTC

The foundation and Endece's Endece Neural LLC subsidiary partnered to develop three undisclosed myelin regeneration drug candidates from Endece for multiple sclerosis (MS). The foundation's Translatio...